Radiotherapy or chemoradiotherapy

RADIATION2 trials

Sponsors

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Eye & ENT Hospital of Fudan University

Conditions

Head and Neck Squamous Cell CarcinomaLocally Advanced Hypopharyngeal CarcinomaNeoadjuvant Therapy

Phase 2

Neoadjuvant PD-1 Inhibitor Combined With Cetuximab in Operable Locally Advanced HNSCC

Not yet recruitingNCT05993858

Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyHead and Neck Squamous Cell Carcinoma, Neoadjuvant Therapy

Start: 2023-10-20End: 2026-12-20Target: 33Updated: 2023-08-15

Neoadjuvant PD-1 Inhibitor Combined With Cetuximab and Platinum in Resectable Locally Advanced Hypopharyngeal Carcinoma

RecruitingNCT06151743

Eye & ENT Hospital of Fudan UniversityLocally Advanced Hypopharyngeal Carcinoma

Start: 2024-01-18End: 2026-12-01Target: 32Updated: 2024-04-30